돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 363340생성일: 2026년 10월 24일

Purine → beta,gamma-Methylene ATP

https://huagongshe.com/ko/reaction/363340

반응식

참여 물질

역할이름HCID투입량
반응물PurineHCID 1044—
반응물5'-AtpHCID 5957—
반응물5'-AdpHCID 6022—
반응물Adenosine MonophosphateHCID 6083—
반응물AdenosineHCID 60961—
생성물beta,gamma-Methylene ATPHCID 91532—
생성물alpha,beta-Methylene-ATPHCID 91557—

반응 단계

Purine compounds (ATP, adenosine 5'-diphosphate (ADP), adenosine 5'-monophosphate (AMP) and adenosine; 3-6 μmol kg-1 and capsaicin (10 μg kg-1) were given as a rapid bolus into the right atrium (5 ml test solution+5 ml physiological saline flush) or the right pulmonary artery (1 ml test solution+3 ml physiological saline flush). When given in the latter site, smaller doses were used, i.e. 0.5-3 μmol kg-1 for purine compounds and 1-5 μg kg-1 for capsaicin. α,β-Methylene ATP (α,β-mATP) and β,γ-methylene ATP (β,γ-mATP) were give as one low dose only (0.75 μmol kg-1) to avoid systemic side effects. Volume controls consisted of either 5+5 ml or 1+3 ml physiological saline. All injections were performed in the same mode by the same person. To exclude involvement of baroreceptors in the recorded neural activity, the latter was monitored before and after a bolus of nitroglycerine (1mg, I.V.; n=5). The effect of ganglionic transmission blockade on the effects of ATP and capsaicin was determined by the administration of hexamethonium (10 mg kg-1, I.V.; n=7).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05874420
출처 데이터셋uspto-grants-1999_02
ORD IDord-a671929f76e2424f9c07f304075d24c3
출처 메모uspto-grants-1999_02